Research Summary
Parkinson＇s disease drugs are medications prescribed to individuals diagnosed with Parkinson＇s disease, a neurodegenerative disorder characterized by the progressive loss of dopamine-producing neurons in the brain. These drugs are primarily aimed at alleviating the motor symptoms of the condition, which include tremors, muscle rigidity, and bradykinesia (slowness of movement). The most commonly prescribed class of drugs for Parkinson＇s disease are levodopa medications, which are converted to dopamine in the brain to help replenish the deficient neurotransmitter. Other drug classes, such as dopamine agonists, MAO-B inhibitors, and COMT inhibitors, are also used to manage symptoms and extend the effectiveness of levodopa. While these drugs can provide significant relief from the motor symptoms, they do not cure Parkinson＇s disease, and their use may be tailored to each patient＇s specific needs and stage of the disease.
According to WENKH research statistics, the global Parkinson Disease Drug market size will reach 7,089 Million USD in 2025 and is projected to reach 10,973 Million USD by 2032, with a CAGR of 6.44% (2025-2032). Among them, the Asia-Pacific Parkinson Disease Drug market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
In recent years, the Parkinson’s disease drug market has entered a period of dynamic transformation, driven largely by breakthroughs in biotechnology and digital health. Traditional dopamine replacement therapies, while still foundational, are increasingly being complemented—or even challenged—by innovative approaches such as gene therapy, neuroprotective agents, and precision drug delivery systems. Companies are racing to develop disease-modifying treatments that do more than manage symptoms, aiming instead to slow or halt disease progression. This shift is fueled by a growing body of neurological research and a clearer understanding of Parkinson’s pathophysiology, especially around α-synuclein aggregation and mitochondrial dysfunction. From a market perspective, this translates into a wave of diversified R&D pipelines and a shift in investment priorities from symptom control to long-term disease interception.
The global Parkinson Disease Drug market is highly competitive, with key market players including Merck, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, Roche, Bausch Health, H.Lundbeck, Supernus Pharmaceuticals, Orion, Stada Arzneimittel, Servier, Recordati, Changzhou Kangpu Pharmaceutical Co., Ltd, CSPC Pharmaceutical Group Limited, Zhejiang Jingxin Pharmaceutical Co., Ltd, Qilu Pharmaceutical, YiChang HEC ChangJiang Pharmaceutical Co., Ltd, ZEIN BIOTECHNOLOGY CO., LTD, Hunan Jiudian Pharmaceutical Co., Ltd, Luye Pharma, Shijiazhuang No.4 Pharmaceutical Co.,Ltd, etc. This report categorizes the competitive landscape of the global Parkinson Disease Drug market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Parkinson Disease Drug market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Parkinson Disease Drug industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Parkinson Disease Drug and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers countries including United States, China, Germany, Japan, France, South Korea, United Kingdom, India, Italy, Brazil, Mexico, Indonesia, Vietnam and South Africa. It particularly focuses on the sales revenue of Parkinson Disease Drug in these countries, as well as the product segmentation and downstream application market size of each country. The report provides an in-depth analysis of the regional distribution and future development trends of the Parkinson Disease Drug market. By considering local policies, this report evaluates the market prospects of Parkinson Disease Drug in each country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Merck
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
Roche
Bausch Health
H.Lundbeck
Supernus Pharmaceuticals
Orion
Stada Arzneimittel
Servier
Recordati
Changzhou Kangpu Pharmaceutical Co., Ltd
CSPC Pharmaceutical Group Limited
Zhejiang Jingxin Pharmaceutical Co., Ltd
Qilu Pharmaceutical
YiChang HEC ChangJiang Pharmaceutical Co., Ltd
ZEIN BIOTECHNOLOGY CO., LTD
Hunan Jiudian Pharmaceutical Co., Ltd
Luye Pharma
Shijiazhuang No.4 Pharmaceutical Co.,Ltd
Product Segment
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Others
Product Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Parkinson Disease Drug Industry Chain Analysis
Chapter 3: Global Parkinson Disease Drug Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Parkinson Disease Drug Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Specifications and Features, Product Revenue and Product Gross Profit Margin)
Chapter 6: Global Parkinson Disease Drug Market Analysis by Countries, Product Segment and Downstream Application
Chapter 7: United States Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 8: China Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 9: Germany Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 10: Japan Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 11: France Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 12: South Korea Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 13: United Kingdom Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 14: India Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 15: Italy Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 16: Brazil Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 17: Mexico Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 18: Indonesia Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 19: Vietnam Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 20: South Africa Parkinson Disease Drug Market Size, Product Segment, Downstream Application Analysis
Chapter 21: Research Conclusion
Chapter 22: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Content
1 Parkinson Disease Drug Market Overview
1.1 Product Definition Introduction
1.2 Global Parkinson Disease Drug Market Size and Growth Forecast Analysis (2020-2032)
1.3 Parkinson Disease Drug Market Status and Development Prospects
1.3.1 Parkinson Disease Drug Market Status
1.3.2 Parkinson Disease Drug Industry Development Prospects
1.4 Parkinson Disease Drug Market Overview by Product Segment
1.4.1 Global Parkinson Disease Drug Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032
1.4.2 Sinemet-CR
1.4.3 Trastal
1.4.4 Madopar
1.4.5 COMT Inhibitor
1.4.6 Others
1.5 Parkinson Disease Drug Market Overview by Product Application
1.5.1 Global Parkinson Disease Drug Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032
1.5.2 Under 40 Years Old
1.5.3 40-65 Years Old
1.5.4 Above 65 Years Old
2 Parkinson Disease Drug Industry Supply Chain Analysis
2.1 Parkinson Disease Drug Supply Chain
2.2 Parkinson Disease Drug Midstream Suppliers
2.3 Parkinson Disease Drug Downstream Customers
2.4 Parkinson Disease Drug Sales Channel Analysis
3 Parkinson Disease Drug Market Environment Analysis
3.1 Parkinson Disease Drug Industry Policy Analysis
3.2 Parkinson Disease Drug Emerging Technology Trends in the Industry
3.3 Parkinson Disease Drug Restraining Factors Analysis
3.4 Parkinson Disease Drug Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Parkinson Disease Drug Market Players Competition Landscape
4.1 Global Parkinson Disease Drug Market Revenue by Key Players (2021-2025)
4.2 Global Parkinson Disease Drug Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Parkinson Disease Drug Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Merck
5.1.1 Merck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Merck Parkinson Disease Drug Product Features
5.1.3 Merck Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.2 GSK
5.2.1 GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 GSK Parkinson Disease Drug Product Features
5.2.3 GSK Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.3 Novartis
5.3.1 Novartis Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Novartis Parkinson Disease Drug Product Features
5.3.3 Novartis Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.4 Boehringer Ingelheim
5.4.1 Boehringer Ingelheim Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Boehringer Ingelheim Parkinson Disease Drug Product Features
5.4.3 Boehringer Ingelheim Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.5 Teva Pharmaceutical
5.5.1 Teva Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 Teva Pharmaceutical Parkinson Disease Drug Product Features
5.5.3 Teva Pharmaceutical Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.6 Abbvie
5.6.1 Abbvie Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Abbvie Parkinson Disease Drug Product Features
5.6.3 Abbvie Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.7 Kyowa Hakko Kirin Pharma
5.7.1 Kyowa Hakko Kirin Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Features
5.7.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.8 Astellas Pharma
5.8.1 Astellas Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Astellas Pharma Parkinson Disease Drug Product Features
5.8.3 Astellas Pharma Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.9 Desitin Arzneimittel
5.9.1 Desitin Arzneimittel Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 Desitin Arzneimittel Parkinson Disease Drug Product Features
5.9.3 Desitin Arzneimittel Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.10 Endo Pharmaceuticals
5.10.1 Endo Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Endo Pharmaceuticals Parkinson Disease Drug Product Features
5.10.3 Endo Pharmaceuticals Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.11 Roche
5.11.1 Roche Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 Roche Parkinson Disease Drug Product Features
5.11.3 Roche Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.12 Bausch Health
5.12.1 Bausch Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.12.2 Bausch Health Parkinson Disease Drug Product Features
5.12.3 Bausch Health Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.13 H.Lundbeck
5.13.1 H.Lundbeck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.13.2 H.Lundbeck Parkinson Disease Drug Product Features
5.13.3 H.Lundbeck Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.14 Supernus Pharmaceuticals
5.14.1 Supernus Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.14.2 Supernus Pharmaceuticals Parkinson Disease Drug Product Features
5.14.3 Supernus Pharmaceuticals Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.15 Orion
5.15.1 Orion Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.15.2 Orion Parkinson Disease Drug Product Features
5.15.3 Orion Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.16 Stada Arzneimittel
5.16.1 Stada Arzneimittel Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.16.2 Stada Arzneimittel Parkinson Disease Drug Product Features
5.16.3 Stada Arzneimittel Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.17 Servier
5.17.1 Servier Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.17.2 Servier Parkinson Disease Drug Product Features
5.17.3 Servier Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.18 Recordati
5.18.1 Recordati Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.18.2 Recordati Parkinson Disease Drug Product Features
5.18.3 Recordati Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.19 Changzhou Kangpu Pharmaceutical Co., Ltd
5.19.1 Changzhou Kangpu Pharmaceutical Co., Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.19.2 Changzhou Kangpu Pharmaceutical Co., Ltd Parkinson Disease Drug Product Features
5.19.3 Changzhou Kangpu Pharmaceutical Co., Ltd Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.20 CSPC Pharmaceutical Group Limited
5.20.1 CSPC Pharmaceutical Group Limited Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.20.2 CSPC Pharmaceutical Group Limited Parkinson Disease Drug Product Features
5.20.3 CSPC Pharmaceutical Group Limited Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.21 Zhejiang Jingxin Pharmaceutical Co., Ltd
5.21.1 Zhejiang Jingxin Pharmaceutical Co., Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.21.2 Zhejiang Jingxin Pharmaceutical Co., Ltd Parkinson Disease Drug Product Features
5.21.3 Zhejiang Jingxin Pharmaceutical Co., Ltd Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.22 Qilu Pharmaceutical
5.22.1 Qilu Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.22.2 Qilu Pharmaceutical Parkinson Disease Drug Product Features
5.22.3 Qilu Pharmaceutical Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.23 YiChang HEC ChangJiang Pharmaceutical Co., Ltd
5.23.1 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.23.2 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Parkinson Disease Drug Product Features
5.23.3 YiChang HEC ChangJiang Pharmaceutical Co., Ltd Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.24 ZEIN BIOTECHNOLOGY CO., LTD
5.24.1 ZEIN BIOTECHNOLOGY CO., LTD Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.24.2 ZEIN BIOTECHNOLOGY CO., LTD Parkinson Disease Drug Product Features
5.24.3 ZEIN BIOTECHNOLOGY CO., LTD Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.25 Hunan Jiudian Pharmaceutical Co., Ltd
5.25.1 Hunan Jiudian Pharmaceutical Co., Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.25.2 Hunan Jiudian Pharmaceutical Co., Ltd Parkinson Disease Drug Product Features
5.25.3 Hunan Jiudian Pharmaceutical Co., Ltd Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.26 Luye Pharma
5.26.1 Luye Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.26.2 Luye Pharma Parkinson Disease Drug Product Features
5.26.3 Luye Pharma Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
5.27 Shijiazhuang No.4 Pharmaceutical Co.,Ltd
5.27.1 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.27.2 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Parkinson Disease Drug Product Features
5.27.3 Shijiazhuang No.4 Pharmaceutical Co.,Ltd Parkinson Disease Drug Product Revenue and Gross Margin Analysis (2021-2025)
6 Global Parkinson Disease Drug Market Analysis by Countries, by Product Segment and Application
6.1 Global Parkinson Disease Drug Market Size and Growth Forecast by Countries: 2020 VS 2025 VS 2032
6.1.1 Global Parkinson Disease Drug Market Revenue by Countries (2020-2025)
6.1.2 Global Parkinson Disease Drug Market Revenue Forecast by Countries (2026-2032)
6.2 Global Parkinson Disease Drug Market Size by Product Segment (2020-2032)
6.3 Global Parkinson Disease Drug Market Size by Product Application (2020-2032)
7 United States Parkinson Disease Drug Market Analysis
7.1 United States Parkinson Disease Drug Market Prospects
7.2 United States Parkinson Disease Drug Market Size by Product Segment (2020-2032)
7.3 United States Parkinson Disease Drug Market Size by Product Application (2020-2032)
8 China Parkinson Disease Drug Market Analysis
8.1 China Parkinson Disease Drug Market Prospects
8.2 China Parkinson Disease Drug Market Size by Product Segment (2020-2032)
8.3 China Parkinson Disease Drug Market Size by Product Application (2020-2032)
9 Germany Parkinson Disease Drug Market Analysis
9.1 Germany Parkinson Disease Drug Market Prospects
9.2 Germany Parkinson Disease Drug Market Size by Product Segment (2020-2032)
9.3 Germany Parkinson Disease Drug Market Size by Product Application (2020-2032)
10 Japan Parkinson Disease Drug Market Analysis
10.1 Japan Parkinson Disease Drug Market Prospects
10.2 Japan Parkinson Disease Drug Market Size by Product Segment (2020-2032)
10.3 Japan Parkinson Disease Drug Market Size by Product Application (2020-2032)
11 France Parkinson Disease Drug Market Analysis
11.1 France Parkinson Disease Drug Market Prospects
11.2 France Parkinson Disease Drug Market Size by Product Segment (2020-2032)
11.3 France Parkinson Disease Drug Market Size by Product Application (2020-2032)
12 South Korea Parkinson Disease Drug Market Analysis
12.1 South Korea Parkinson Disease Drug Market Prospects
12.2 South Korea Parkinson Disease Drug Market Size by Product Segment (2020-2032)
12.3 South Korea Parkinson Disease Drug Market Size by Product Application (2020-2032)
13 United Kingdom Parkinson Disease Drug Market Analysis
13.1 United Kingdom Parkinson Disease Drug Market Prospects
13.2 United Kingdom Parkinson Disease Drug Market Size by Product Segment (2020-2032)
13.3 United Kingdom Parkinson Disease Drug Market Size by Product Application (2020-2032)
14 India Parkinson Disease Drug Market Analysis
14.1 India Parkinson Disease Drug Market Prospects
14.2 India Parkinson Disease Drug Market Size by Product Segment (2020-2032)
14.3 India Parkinson Disease Drug Market Size by Product Application (2020-2032)
15 Italy Parkinson Disease Drug Market Analysis
15.1 Italy Parkinson Disease Drug Market Prospects
15.2 Italy Parkinson Disease Drug Market Size by Product Segment (2020-2032)
15.3 Italy Parkinson Disease Drug Market Size by Product Application (2020-2032)
16 Brazil Parkinson Disease Drug Market Analysis
16.1 Brazil Parkinson Disease Drug Market Prospects
16.2 Brazil Parkinson Disease Drug Market Size by Product Segment (2020-2032)
16.3 Brazil Parkinson Disease Drug Market Size by Product Application (2020-2032)
17 Mexico Parkinson Disease Drug Market Analysis
17.1 Mexico Parkinson Disease Drug Market Prospects
17.2 Mexico Parkinson Disease Drug Market Size by Product Segment (2020-2032)
17.3 Mexico Parkinson Disease Drug Market Size by Product Application (2020-2032)
18 Indonesia Parkinson Disease Drug Market Analysis
18.1 Indonesia Parkinson Disease Drug Market Prospects
18.2 Indonesia Parkinson Disease Drug Market Size by Product Segment (2020-2032)
18.3 Indonesia Parkinson Disease Drug Market Size by Product Application (2020-2032)
19 Vietnam Parkinson Disease Drug Market Analysis
19.1 Vietnam Parkinson Disease Drug Market Prospects
19.2 Vietnam Parkinson Disease Drug Market Size by Product Segment (2020-2032)
19.3 Vietnam Parkinson Disease Drug Market Size by Product Application (2020-2032)
20 South Africa Parkinson Disease Drug Market Analysis
20.1 South Africa Parkinson Disease Drug Market Prospects
20.2 South Africa Parkinson Disease Drug Market Size by Product Segment (2020-2032)
20.3 South Africa Parkinson Disease Drug Market Size by Product Application (2020-2032)
21 Research Conclusion
22 Appendix
22.1 Methodology/Research Approach
22.2 Research Landscape
22.3 Research Benchmark and Hypothesis
22.4 Data Source
22.4.1 Primary Sources
22.4.2 Secondary Sources
22.5 Data Cross Validation
22.6 Disclaimer
Table 1：Global Parkinson Disease Drug Market Size and Growth Forecast Analysis by Product Segment (2020 VS 2025 VS 2032) & (Million USD)
Table 2：Global Parkinson Disease Drug Market Size and Growth Forecast Analysis by Product Application (2020 VS 2025 VS 2032) & (Million USD)
Table 3：Parkinson Disease Drug Downstream Customers List
Table 4：Parkinson Disease Drug Distributors/Dealers List
Table 5：Global Parkinson Disease Drug Market Revenue by Key Players (2021-2025) & (Million USD)
Table 6：Global Parkinson Disease Drug Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Parkinson Disease Drug Market Expansion and M&A Dynamic
Table 9：Merck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Merck Parkinson Disease Drug Product Features
Table 11：Merck Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 12：GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 13：GSK Parkinson Disease Drug Product Features
Table 14：GSK Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 15：Novartis Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 16：Novartis Parkinson Disease Drug Product Features
Table 17：Novartis Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 18：Boehringer Ingelheim Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 19：Boehringer Ingelheim Parkinson Disease Drug Product Features
Table 20：Boehringer Ingelheim Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 21：Teva Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 22：Teva Pharmaceutical Parkinson Disease Drug Product Features
Table 23：Teva Pharmaceutical Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 24：Abbvie Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Abbvie Parkinson Disease Drug Product Features
Table 26：Abbvie Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 27：Kyowa Hakko Kirin Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 28：Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Features
Table 29：Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 30：Astellas Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 31：Astellas Pharma Parkinson Disease Drug Product Features
Table 32：Astellas Pharma Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 33：Desitin Arzneimittel Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 34：Desitin Arzneimittel Parkinson Disease Drug Product Features
Table 35：Desitin Arzneimittel Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 36：Endo Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 37：Endo Pharmaceuticals Parkinson Disease Drug Product Features
Table 38：Endo Pharmaceuticals Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 39：Roche Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：Roche Parkinson Disease Drug Product Features
Table 41：Roche Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 42：Bausch Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 43：Bausch Health Parkinson Disease Drug Product Features
Table 44：Bausch Health Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 45：H.Lundbeck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 46：H.Lundbeck Parkinson Disease Drug Product Features
Table 47：H.Lundbeck Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 48：Supernus Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 49：Supernus Pharmaceuticals Parkinson Disease Drug Product Features
Table 50：Supernus Pharmaceuticals Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 51：Orion Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 52：Orion Parkinson Disease Drug Product Features
Table 53：Orion Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 54：Stada Arzneimittel Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 55：Stada Arzneimittel Parkinson Disease Drug Product Features
Table 56：Stada Arzneimittel Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 57：Servier Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 58：Servier Parkinson Disease Drug Product Features
Table 59：Servier Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 60：Recordati Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 61：Recordati Parkinson Disease Drug Product Features
Table 62：Recordati Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 63：Changzhou Kangpu Pharmaceutical Co., Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 64：Changzhou Kangpu Pharmaceutical Co., Ltd Parkinson Disease Drug Product Features
Table 65：Changzhou Kangpu Pharmaceutical Co., Ltd Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 66：CSPC Pharmaceutical Group Limited Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 67：CSPC Pharmaceutical Group Limited Parkinson Disease Drug Product Features
Table 68：CSPC Pharmaceutical Group Limited Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 69：Zhejiang Jingxin Pharmaceutical Co., Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 70：Zhejiang Jingxin Pharmaceutical Co., Ltd Parkinson Disease Drug Product Features
Table 71：Zhejiang Jingxin Pharmaceutical Co., Ltd Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 72：Qilu Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 73：Qilu Pharmaceutical Parkinson Disease Drug Product Features
Table 74：Qilu Pharmaceutical Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 75：YiChang HEC ChangJiang Pharmaceutical Co., Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 76：YiChang HEC ChangJiang Pharmaceutical Co., Ltd Parkinson Disease Drug Product Features
Table 77：YiChang HEC ChangJiang Pharmaceutical Co., Ltd Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 78：ZEIN BIOTECHNOLOGY CO., LTD Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 79：ZEIN BIOTECHNOLOGY CO., LTD Parkinson Disease Drug Product Features
Table 80：ZEIN BIOTECHNOLOGY CO., LTD Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 81：Hunan Jiudian Pharmaceutical Co., Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 82：Hunan Jiudian Pharmaceutical Co., Ltd Parkinson Disease Drug Product Features
Table 83：Hunan Jiudian Pharmaceutical Co., Ltd Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 84：Luye Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 85：Luye Pharma Parkinson Disease Drug Product Features
Table 86：Luye Pharma Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 87：Shijiazhuang No.4 Pharmaceutical Co.,Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 88：Shijiazhuang No.4 Pharmaceutical Co.,Ltd Parkinson Disease Drug Product Features
Table 89：Shijiazhuang No.4 Pharmaceutical Co.,Ltd Parkinson Disease Drug Revenue (Million USD) and Gross Margin (2021-2025)
Table 90：Global Parkinson Disease Drug Market Size and Growth Forecast by Countries (2020 VS 2025 VS 2032) & (Million USD)
Table 91：Global Parkinson Disease Drug Market Revenue by Countries (2020-2025) & (Million USD)
Table 92：Global Parkinson Disease Drug Market Share by Countries (2020-2025)
Table 93：Global Parkinson Disease Drug Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 94：Global Parkinson Disease Drug Market Share Forecast by Countries (2026-2032)
Table 95：Global Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 96：Global Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 97：Global Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 98：Global Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 99：United States Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 100：United States Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 101：United States Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 102：United States Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 103：China Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 104：China Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 105：China Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 106：China Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 107：Germany Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 108：Germany Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 109：Germany Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 110：Germany Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 111：Japan Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 112：Japan Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 113：Japan Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 114：Japan Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 115：France Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 116：France Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 117：France Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 118：France Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 119：South Korea Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 120：South Korea Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 121：South Korea Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 122：South Korea Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 123：United Kingdom Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 124：United Kingdom Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 125：United Kingdom Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 126：United Kingdom Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 127：India Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 128：India Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 129：India Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 130：India Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 131：Italy Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 132：Italy Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 133：Italy Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 134：Italy Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 135：Brazil Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 136：Brazil Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 137：Brazil Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 138：Brazil Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 139：Mexico Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 140：Mexico Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 141：Mexico Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 142：Mexico Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 143：Indonesia Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 144：Indonesia Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 145：Indonesia Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 146：Indonesia Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 147：Vietnam Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 148：Vietnam Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 149：Vietnam Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 150：Vietnam Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 151：South Africa Parkinson Disease Drug Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 152：South Africa Parkinson Disease Drug Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 153：South Africa Parkinson Disease Drug Market Revenue by Product Application (2020-2025) & (Million USD)
Table 154：South Africa Parkinson Disease Drug Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 155：Secondary Sources
Figure 1：Parkinson Disease Drug Product Scope
Figure 2：Global Parkinson Disease Drug Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)
Figure 3：Global Parkinson Disease Drug Product Segment Market Share (2025 & 2032)
Figure 4：Global Parkinson Disease Drug Product Application Market Share (2025 & 2032)
Figure 5：Sinemet-CR Product Scope
Figure 6：Trastal Product Scope
Figure 7：Madopar Product Scope
Figure 8：COMT Inhibitor Product Scope
Figure 9：Others Product Scope
Figure 10：Under 40 Years Old Product Scope
Figure 11：40-65 Years Old Product Scope
Figure 12：Above 65 Years Old Product Scope
Figure 13：Parkinson Disease Drug Industrial Chain Framework
Figure 14：Global Parkinson Disease Drug Market by Geographic Segmentation in 2025
Figure 15：Global Parkinson Disease Drug Market Share by Countries (2020 VS 2025)
Figure 16：United States Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 17：China Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 18：Germany Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 19：Japan Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 20：France Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 21：South Korea Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 22：United Kingdom Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 23：India Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 24：Italy Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 25：Brazil Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 26：Mexico Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 27：Indonesia Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 28：Vietnam Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 29：South Africa Parkinson Disease Drug Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 30：Research Methodology
Figure 31：Primary Sources
Figure 32：Data Cross Validation
Global Parkinson Disease Drug Revenue and Market Share by Key Players
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Merck | XX | XX | XX | XX | XX |
| GSK | XX | XX | XX | XX | XX |
| Novartis | XX | XX | XX | XX | XX |
| Boehringer Ingelheim | XX | XX | XX | XX | XX |
| Teva Pharmaceutical | XX | XX | XX | XX | XX |
| Abbvie | XX | XX | XX | XX | XX |
| Kyowa Hakko Kirin Pharma | XX | XX | XX | XX | XX |
| Astellas Pharma | XX | XX | XX | XX | XX |
| Desitin Arzneimittel | XX | XX | XX | XX | XX |
| Endo Pharmaceuticals | XX | XX | XX | XX | XX |
| Roche | XX | XX | XX | XX | XX |
| Bausch Health | XX | XX | XX | XX | XX |
| H.Lundbeck | XX | XX | XX | XX | XX |
| Supernus Pharmaceuticals | XX | XX | XX | XX | XX |
| Orion | XX | XX | XX | XX | XX |
| Stada Arzneimittel | XX | XX | XX | XX | XX |
| Servier | XX | XX | XX | XX | XX |
| Recordati | XX | XX | XX | XX | XX |
| Changzhou Kangpu Pharmaceutical Co., Ltd | XX | XX | XX | XX | XX |
| CSPC Pharmaceutical Group Limited | XX | XX | XX | XX | XX |
| Zhejiang Jingxin Pharmaceutical Co., Ltd | XX | XX | XX | XX | XX |
| Qilu Pharmaceutical | XX | XX | XX | XX | XX |
| YiChang HEC ChangJiang Pharmaceutical Co., Ltd | XX | XX | XX | XX | XX |
| ZEIN BIOTECHNOLOGY CO., LTD | XX | XX | XX | XX | XX |
| Hunan Jiudian Pharmaceutical Co., Ltd | XX | XX | XX | XX | XX |
| Luye Pharma | XX | XX | XX | XX | XX |
| Shijiazhuang No.4 Pharmaceutical Co.,Ltd | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
English
Related Reports 
